Reported Nov 10, 2021 · Terminated
Cubicin (daptomycin for injection), 500 mg per vial, Single-dose vial, Rx only. Manuf. for: Merck Sharp & Dohme Corp.,…
Merck Sharp & Dohme Corp.
High riskUsing this product could cause serious injury, illness or death — stop using it now.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: MERCK SHARP & DOHME CORP · 1 Merck Dr · Whitehouse Station, NJ · 08889-3400
Is this the product you have?
- Cubicin (daptomycin for injection), 500 mg per vial, Single-dose vial, Rx only. Manuf
- forMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ 08889, USA. Manuf
- byBaxter Pharmaceuticals LLC., Bloomington, IN 47403, USA
- NDC67919-011-01
- Lot codes and dates
Lot #: 934778Exp. Date Jun 2022
- Amount recalled
- 76,163 vials
Where it was sold
- Nationwide
Why it was recalled
Stop using this product now
Presence of Particulate Matter: Identified as Glass Particles
Using this product could cause serious injury, illness or death — stop using it now.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Merck Sharp & Dohme Corp. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.